The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.

A metal tetradentate complex is disclosed in which an imidazole moiety is used as a linker in the ligand. The complex is useful as an emitter or other functional roles in an OLED device.

An organometallic compound represented by Formula 1:
M(L.sub.1).sub.n1(L.sub.2).sub.n2(L.sub.3).sub.n3  Formula 1 wherein M, L.sub.1, L.sub.2, L.sub.3, n1, n2, and n3 are the same as described in the specification.

An organic light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer. The emission layer includes at least one organometallic compound of Formula 1, and at least one selected from a second compound and a third compound, where the organometallic compound, the second compound, and the third compound are different from each other. When the emission layer comprises both the second compound and the third compound, the second compound and the third compound form an exciplex, and the organometallic compound and the second compound and/or the third compound do not form an exciplex:
M(L.sub.1).sub.n1(L.sub.2).sub.n2,  Formula 1
wherein in Formula 1, L.sub.1 is represented by Formula 2-1: ##STR00001##

Provided are an organic electric element comprising as a phosphorescent host material, a mixture of the compounds of Formula (1) and Formula (2), and an organic electronic device or apparatus thereof for achieving a high luminous efficiency, a low driving voltage, and an improved lifespan.

Provided are an organic electroluminescent material and device. The organic electroluminescent material is a metal complex comprising a ligand L.sub.a having a structure of Formula 1. When applied to organic electroluminescent devices, these metal complexes can provide very good device performance, especially an extended device lifetime and improved device efficiency and have a huge application prospect in aspects of white and low blue light sources. Further provided are an organic electroluminescent device comprising the metal complex and a compound composition comprising the metal complex.

Devices having multiple multicomponent emissive layers are provided, where each multicomponent EML includes at least three components. Each of the components in each EML is a host material or an emitter. The devices have improved color stability and relatively high luminance.

A compound comprising a first ligand L.sub.A of Formula I

##STR00001##

is described. In Formula I, X.sup.1 and X.sup.6 to X.sup.10 are each independently C or N; X.sup.2 is CR.sup.1′ or N; X.sup.3 is CR.sup.1 or N; X.sup.4 is CR.sup.2 or N; X.sup.5 is CR.sup.3 or N; each R.sup.1, R.sup.2, R.sup.3, R.sup.A, R.sup.B, and R.sup.C is independently a hydrogen or a General Substituent; any two substituents may be joined or fused to form a ring; at least one of R.sup.1′, R.sup.1, R.sup.2, and R.sup.3 is a partially or fully deuterated alkyl or cycloalkyl group; at least one pair of R.sup.C are joined or fused to form a 5-membered or 6-membered ring. Formulations, OLEDs, and consumer products comprising the compound are also described.

A composition including a first compound and a second compound, wherein the first compound is an organometallic compound including platinum and a tetradentate ligand bound thereto, and the second compound is an organometallic compound including iridium, μ(Pt) is about 0.5 debye to about 5.0 debye, μ(Pt) is less than μ(Ir), μ(Pt) is a dipole moment of the first compound, μ(Ir) is a dipole moment of the second compound, and each of μ(Pt) and μ(Ir) is calculated based on density functional theory as described herein.

An organometallic compound, represented by Formula 1:

M.sub.1(Ln.sub.1).sub.n1(Ln.sub.2).sub.n2  Formula 1

wherein, in Formula 1, M.sub.1 is a transition metal, Ln.sub.1 is a ligand represented by Formula 1-1, Ln.sub.2 is a ligand represented by Formula 2-1 or 2-2, n1 is 1 or 2, and n2 is 1 or 2:

##STR00001## wherein, in Formulae 1-1, 2-1, and 2-2, CY.sub.1, X.sub.21 to X.sub.28, X.sub.31, X.sub.32, R.sub.10, R.sub.31 to R.sub.37, R.sub.41 to R.sub.44, and b10 are as defined herein, and * and *′ each indicates a binding site to M.sub.1.